Cargando…
An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid
SIMPLE SUMMARY: Radiosensitization of glioblastoma is a major ambition to increase the survival of this incurable cancer. Before surgery, oral administration of 5-aminolevulinic acid leads to the accumulation of fluorescent protoporphyrin IX, preferentially in the cancer cells rather than in the nor...
Autores principales: | Dupin, Charles, Sutter, Jade, Amintas, Samuel, Derieppe, Marie-Alix, Lalanne, Magalie, Coulibaly, Soule, Guyon, Joris, Daubon, Thomas, Boutin, Julian, Blouin, Jean-Marc, Richard, Emmanuel, Moreau-Gaudry, François, Bedel, Aurélie, Vendrely, Véronique, Dabernat, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454704/ https://www.ncbi.nlm.nih.gov/pubmed/36077783 http://dx.doi.org/10.3390/cancers14174244 |
Ejemplares similares
-
Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
por: Amintas, Samuel, et al.
Publicado: (2021) -
Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells
por: Prat, Florence, et al.
Publicado: (2020) -
Circulating Tumor Cell Clusters: United We Stand Divided We Fall
por: Amintas, Samuel, et al.
Publicado: (2020) -
In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy
por: Takahashi, Junko, et al.
Publicado: (2021) -
Radiodynamic therapy with CsI(na)@MgO nanoparticles and 5-aminolevulinic acid
por: Jiang, Fangchao, et al.
Publicado: (2022)